» Articles » PMID: 19479824

Remnants of Secondarily Necrotic Cells Fuel Inflammation in Systemic Lupus Erythematosus

Overview
Journal Arthritis Rheum
Specialty Rheumatology
Date 2009 May 30
PMID 19479824
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Patients with systemic lupus erythematosus (SLE) are often characterized by cellular as well as humoral deficiencies in the recognition and phagocytosis of dead and dying cells. The aim of this study was to investigate whether the remnants of apoptotic cells are involved in the induction of inflammatory cytokines in blood-borne phagocytes.

Methods: We used ex vivo phagocytosis assays comprising cellular and humoral components and phagocytosis assays with isolated granulocytes and monocytes to study the phagocytosis of secondarily necrotic cell-derived material (SNEC). Cytokines were measured by multiplex bead array technology.

Results: We confirmed the impaired uptake of various particulate targets, including immunoglobulin-opsonized beads, by granulocytes and monocytes from patients with SLE compared with healthy control subjects. Surprisingly, blood-borne phagocytes from two-thirds of the patients with SLE took up SNEC, which was rarely phagocytosed by phagocytes from healthy control subjects or patients with rheumatoid arthritis. Supplementation of healthy donor blood with IgG fractions derived from patients with SLE transferred the capability to take up SNEC to the phagocytes of healthy donors. Phagocytosis-promoting immune globulins also induced secretion of huge amounts of cytokines by blood-borne phagocytes following uptake of SNEC.

Conclusion: Opsonization of SNEC by autoantibodies from patients with SLE fosters its uptake by blood-borne monocytes and granulocytes. Autoantibody-mediated phagocytosis of SNEC is accompanied by secretion of inflammatory cytokines, fueling the inflammation that contributes to the perpetuation of autoimmunity in SLE.

Citing Articles

Proteolysis of TAM receptors in autoimmune diseases and cancer: what does it say to us?.

Malikova I, Worth A, Aliyeva D, Khassenova M, Kriajevska M, Tulchinsky E Cell Death Dis. 2025; 16(1):155.

PMID: 40044635 PMC: 11883011. DOI: 10.1038/s41419-025-07480-9.


Macrophage WDFY3, a protector against autoimmunity.

Wu X, Wang Z, Croce K, Li F, Cui J, DAgati V bioRxiv. 2024; .

PMID: 39229152 PMC: 11370343. DOI: 10.1101/2024.08.17.608411.


The shared circulating diagnostic biomarkers and molecular mechanisms of systemic lupus erythematosus and inflammatory bowel disease.

Sun H, Zhang X, Shen C Front Immunol. 2024; 15:1354348.

PMID: 38774864 PMC: 11106441. DOI: 10.3389/fimmu.2024.1354348.


Defining the Role of Monocytes in Sjögren's Syndrome.

Sequi-Sabater J, Beretta L Int J Mol Sci. 2022; 23(21).

PMID: 36361554 PMC: 9654893. DOI: 10.3390/ijms232112765.


Tuberculosis and Autoimmunity.

Belyaeva I, Kosova A, Vasiliev A Pathophysiology. 2022; 29(2):298-318.

PMID: 35736650 PMC: 9228380. DOI: 10.3390/pathophysiology29020022.